EU Q1 Sales Round-Up: Karo Pharma, Boiron And Ipsen
Executive Summary
Consumer health first-quarter results round-up featuring Karo Pharma, Boiron and Ipsen.
You may also be interested in...
Boiron Posts Big Sales Gain As It Benefits From Easy Comp
French homeopathy specialist Boiron reported sales up by 60% in Q1 as the business returned to growth following the end of COVID-19 social restrictions.
Ipsen Weighing Consumer Business Sale After Challenging 2020
Ipsen CEO David Loew has kicked off a strategic review of the company's "non core" Consumer Healthcare business, which has endured a particularly tough year thanks to the COVID-19 pandemic.
France's Boiron Diversifies Into Probiotics To Arrest Sales Decline
Homeopathy specialist Boiron its diversifying its offering into the increasingly popular probiotics segment with launches underway in France, Italy and Spain, as well as Eastern Europe.